PROFIL DAN PERBANDINGAN PENGOBATAN PASIEN COVID-19 DI RSUD dr. SOEKARDJO
Total View This Week0
Total View This Week0
Institusion
UNIVERSITAS BAKTI TUNAS HUSADA
Author
FUJIYANTI, VINA
Subject
S1-Skripsi Farmasi
Datestamp
2022-09-19 07:21:37
Abstract :
ABSTRAK COVID-19 merupakan suatu penyakit menular yang diakibatkan oleh infeksi coronavirus merupakan jenis baru memiliki gejala demam, batuk kering, dan sesak napas yang dapat diatasi dengan berbagai metode salah satunya mengggunakan penatalaksanaan farmakoterapi dengan menggunakan obat-obatan COVID-19. Penelitian ini bertujuan untuk mengetahui efek dari penggunaan obat-obatan COVID-19. Penelitian dilaksanaan pada 1 Maret 2020 sampai 1 Maret 2021 di RSUD dr. Soekardjo Tasikmalaya pengambilan data menggunakan metode slovin sampling dan teknik pengolahan data dengan medcalc risk relatives. Pengambilan data dilakukan berdasarkan penelaahan rekam medik. Hasil penelitian menunjukan bahwa pada perbandingan obat terdapat perbedaan yang signifikan cp <0,05 pada kombinasi favipiravir dan hidroksiklorokuin menurunkan resiko kematian sebanyak 22 kali lipat, dibandingkan favipiravir dan hidroksiklorokuin sebagai monoterapi. Kata kunci: COVID-19, Favipiravir, Hidroksiklorokuin, Monoterapi, Efektivitas ABSTRACT COVID-19 is an infectious disease caused by infection that has symptoms such as fever, dry cough, and shortness of breath which can be overcome by various methods, such as pharmacotherapy management using COVID-19 drugs. The study aims to determine the effect of the COVID-19 drugs administration. The study was carried out on March 1, 2020 to March 1, 2021 at dr. Soekardjo Tasikmalaya hospital data collection using slovin sampling method and data processing with the medcalc risk relatives. The data collection was carried out based on a review of medical records. The results showed that in the comparison of drugs, there was a significant difference cp <0,05 in the combination of favipiravir and hydroxychloroquine, which reducing the risk of death by 22 times, conpared to favipiravir and hydroxychloroquine monotherapy. Keywords: COVID-19, Favipiravir, Hydroxychloroquine, Monotherapy, Effectiveness
ABSTRAK COVID-19 merupakan suatu penyakit menular yang diakibatkan oleh infeksi coronavirus merupakan jenis baru memiliki gejala demam, batuk kering, dan sesak napas yang dapat diatasi dengan berbagai metode salah satunya mengggunakan penatalaksanaan farmakoterapi dengan menggunakan obat-obatan COVID-19. Penelitian ini bertujuan untuk mengetahui efek dari penggunaan obat-obatan COVID-19. Penelitian dilaksanaan pada 1 Maret 2020 sampai 1 Maret 2021 di RSUD dr. Soekardjo Tasikmalaya pengambilan data menggunakan metode slovin sampling dan teknik pengolahan data dengan medcalc risk relatives. Pengambilan data dilakukan berdasarkan penelaahan rekam medik. Hasil penelitian menunjukan bahwa pada perbandingan obat terdapat perbedaan yang signifikan cp <0,05 pada kombinasi favipiravir dan hidroksiklorokuin menurunkan resiko kematian sebanyak 22 kali lipat, dibandingkan favipiravir dan hidroksiklorokuin sebagai monoterapi. Kata kunci: COVID-19, Favipiravir, Hidroksiklorokuin, Monoterapi, Efektivitas ABSTRACT COVID-19 is an infectious disease caused by infection that has symptoms such as fever, dry cough, and shortness of breath which can be overcome by various methods, such as pharmacotherapy management using COVID-19 drugs. The study aims to determine the effect of the COVID-19 drugs administration. The study was carried out on March 1, 2020 to March 1, 2021 at dr. Soekardjo Tasikmalaya hospital data collection using slovin sampling method and data processing with the medcalc risk relatives. The data collection was carried out based on a review of medical records. The results showed that in the comparison of drugs, there was a significant difference cp <0,05 in the combination of favipiravir and hydroxychloroquine, which reducing the risk of death by 22 times, conpared to favipiravir and hydroxychloroquine monotherapy. Keywords: COVID-19, Favipiravir, Hydroxychloroquine, Monotherapy, Effectiveness
Download
book
BibTex
Latex, Jabref
cloud_download
Original Resource
url resource Institution
